ARTICLE | Distillery Therapeutics
Neurology
January 18, 2017 7:09 PM UTC
Mouse studies suggest inhibiting NAT8L could help treat Canavan disease. In a mouse model of the disease, knockout of NAT8L decreased vacuolation of the cerebellum, swelling of Purkinje cell axons and...
BCIQ Company Profiles
BCIQ Target Profiles